eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | carcinoma, squamous cell |
| Comorbidity | C0302592|cervical ca |
| Sentences | 8 |
| PubMedID- 20846255 | Aim: we aimed to define the long-term follow-up results in cervical cancer patients with unexplained squamous cell carcinoma antigen (scc-ag) elevation (negative conventional imaging studies, computed tomography or magnetic resonance imaging) after definitive treatment using positron emission tomography (pet). |
| PubMedID- 25661329 | Methods: a retrospective analysis was performed of stage ib-iia cervical cancer patients with adenocarcinoma or adenosquamous carcinoma who underwent radical hysterectomy at seoul national university hospital between 1998 and 2008. |
| PubMedID- 24772127 | According to the american cancer society, more than 12,200 american women were diagnosed as invasive cervical cancer in 2010, of which squamous cell carcinoma was most common. |
| PubMedID- 20133337 | Conclusions: these results indicated that the plasma human papillomavirus dna level could be potentially used as a marker of low-invasive cervical cancer tumors in patients with normal squamous cell carcinoma antigen levels before treatment. |
| PubMedID- 24711756 | No significant statistical differences have been found between two groups about age (median age was 49 for schauta and 54 for piver p=0.494) and parity of the patients (median parity was 2 (range: 0-5) for piver ii group and 1 (range: 0-4) for schauta group (p=0.607)) and about histotype and stage of the cervical cancer (34 patients with squamous cell carcinoma among piver ii group vs 16 patients from schauta group; 4 women with adenocarcinoma from piver ii group vs 1 subject from the schauta group; p value 1.000). |
| PubMedID- 25860888 | The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study. |
| PubMedID- 25913134 | Objective: to determine whether pretreatment cyfra 21-1 levels can be a useful prognostic indicator in cervical cancer with reference to squamous cell carcinoma-antigen (scc-ag). |
| PubMedID- 25312397 | Comparison of adenocarcinoma and adenosquamous carcinoma in patients with early-stage cervical cancer after radical surgery. |
Page: 1